Since IGFBP3 exhibits antitumor properties in ESCC cells and IGFBP3 expression was significantly decreased in ESCC tissues, cytoplasmic PURα may mediate ESCC progression by regulating mRNA translation [55]. The gene discussed is IGFBP3; the disease is esophageal squamous cell carcinoma.